e-learning
resources
Virtual 2020
Pre-Congress Content
Clinical studies of COPD: combination inhalers and much more
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Involvement of airway eosinophilia and airway hyperresponsiveness in management and therapy for COPD>
H. Kume (Sennan, Japan), M. Hojo (Tokyo, Japan), N. Hashimoto (Nagoya, Japan)
Source:
Virtual Congress 2020 – Clinical studies of COPD: combination inhalers and much more
Session:
Clinical studies of COPD: combination inhalers and much more
Session type:
E-poster session
Number:
985
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
H. Kume (Sennan, Japan), M. Hojo (Tokyo, Japan), N. Hashimoto (Nagoya, Japan). Involvement of airway eosinophilia and airway hyperresponsiveness in management and therapy for COPD>. 985
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Observational cohort study of pulmonary exacerbations in alpha-1 antitrypsin deficiency
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Related content which might interest you:
Same role and same treatment for airway eosinophilia in asthma and COPD?
Source: Eur Respir J 2007; 29: 831-833
Year: 2007
Increased airway closure is a determinant of airway hyperresponsiveness
Source: Eur Respir J 2008; 32: 1563-1569
Year: 2008
Sputum eosinophilia, airway hyperresponsiveness and airway narrowing in young adults with former asthma
Source: Eur Respir J 2005; 26: Suppl. 49, 733s
Year: 2005
Role of tissue kallikrein 1 in late phase bronchoconstriction and airway hyperresponsiveness
Source: Annual Congress 2006 - Basic mechanisms of allergic airways inflammation
Year: 2006
Budesonide prevents but does not reverse sustained airway hyperresponsiveness in mice
Source: Eur Respir J 2008; 32: 970-978
Year: 2008
Monitoring asthma in children: lung function, bronchial hyperresponsiveness and inflammation
Source: International Congress 2014 – Monitoring asthma in children: results of the ERS Task Force
Year: 2014
Small airways involvement is associated with bronchial hyperresponsiveness in asthma
Source: Annual Congress 2012 - Different ways to phenotype asthma
Year: 2012
Allergen-induced nonspecific bronchial hyperresponsiveness in patients with intermittent asthma
Source: Annual Congress 2009 - Airway hyperresponsiveness: mechanism and assessment
Year: 2009
Airway inflammation in symptomatic and asymptomatic subjects with and without airway hyperresponsiveness
Source: Eur Respir J 2001; 18: Suppl. 33, 315s
Year: 2001
Bronchial reversibility and airway inflammation in patients with COPD
Source: Eur Respir J 2003; 22: Suppl. 45, 436s
Year: 2003
Effect of bronchial neutrophilia on airway remodeling in asthma
Source: International Congress 2019 – Cellular responses and cell therapy in lung injury and repair
Year: 2019
Small airways and hyperresponsiveness in asthma and COPD
Source: International Congress 2017 – Sadoul Lecture: "Airway hyperresponsiveness: the riddle of asthma and COPD" and related topics
Year: 2017
Galectn-3 : marker of airway inflammation in bronchial asthma
Source: International Congress 2018 – Studying novel biomarkers in asthma and COPD
Year: 2018
Airway resistance at maximum inhalation as a marker of asthma and airway hyperresponsiveness in children
Source: Annual Congress 2012 - Asthma: assessment and treatment
Year: 2012
Airway remedeling in a mouse model of chronic asthma: relation between the degree of airway remodeling and airway hyperresponsiveness
Source: Eur Respir J 2004; 24: Suppl. 48, 38s
Year: 2004
Airway hyperresponsiveness in children
Source: Eur Respir Mon 2012; 56: 158-171
Year: 2012
F
eNO
-based asthma management results in faster improvement of airway hyperresponsiveness
Source: ERJ Open Res, 4 (4) 00147-2017; 10.1183/23120541.00147-2017
Year: 2018
Clinical and inflammatory determinants of bronchial hyperresponsiveness in COPD
Source: Eur Respir J 2012; 40: 1098-1105
Year: 2012
Airway inflammation and airway pathophysiology in older asthmatics
Source: Annual Congress 2011 - New mechanisms in airway disease
Year: 2011
Markers of airway inflammation and airway hyperresponsiveness in patients with well-controlled asthma
Source: Eur Respir J 2001; 18: 444-450
Year: 2001
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept